Seema Patel

Title: Seema Patel: Innovator in Humanised Antibody Development

Introduction

Seema Patel is a distinguished inventor based in Greater London, GB. She has made significant contributions to the field of biotechnology, particularly in the development of humanised antibodies. Her work focuses on enhancing the efficacy of therapeutic antibodies for medical applications.

Latest Patents

Seema Patel holds a patent for a humanised anti-IL17BR antibody. This invention relates to humanised versions of the murine anti-IL17BR antibody D9.2, which comprise mutations of certain residues within the heavy chain and/or light chain variable domains. These modifications display improved expression without deleterious effects on specificity or affinity. The humanised antibodies may include a heavy chain variable (VH) domain with specific sequences, as well as a light chain variable (VL) domain that also comprises defined sequences. This innovation has potential applications in the treatment of cancer, showcasing the therapeutic promise of her work.

Career Highlights

Seema Patel is currently associated with Lifearc, where she continues to advance her research in antibody development. Her expertise in biotechnology and her innovative approach have positioned her as a key figure in her field.

Collaborations

Seema collaborates with David Matthews, leveraging their combined expertise to further their research initiatives.

Conclusion

Seema Patel's contributions to the field of humanised antibodies exemplify the impact of innovative research in biotechnology. Her work not only advances scientific knowledge but also holds promise for future medical therapies.